跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
melanocortin-4 receptor modulators (obesity)
首页
药物
melanocortin-4 receptor modulators (obesity)
melanocortin-4 receptor modulators (obesity)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
申请人: SANTHERA PHARMACEUTICALS CH
优先权: 2007
CN
EP
US
3 件公开
Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
申请人: SANTHERA PHARMACEUTICALS CH
优先权: 2006
EP
Phenylpiperidine derivatives as melanocortin-4 receptor modulators
申请人: SANTHERA PHARMACEUTICALS CH
优先权: 2006
EP
US
2 件公开
Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
申请人: SANTHERA PHARMACEUTICALS CH
优先权: 2007
EP
Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
申请人: MYOCONTRACT LTD
优先权: 2003
EP
US
2 件公开
Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
申请人: MYOCONTRACT LTD
优先权: 2003
EP
US
2 件公开
Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
申请人: MYOCONTRACT LTD
优先权: 2003
EP
US
2 件公开
Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
申请人: SOEBERDT MICHAEL
优先权: 2003
US
药物
反馈
